Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 10, 2015
Transcriptional corepressor MTG16 regulates small intestinal crypt proliferation and crypt regeneration after radiation-induced injuryShenika V Poindexter, Vishruth K Reddy, Mukul K Mittal, et al.
The Journal of Clinical Investigation|August 8, 2013
HDAC3 is essential for DNA replication in hematopoietic progenitor cellsAlyssa R Summers, Melissa A Fischer, Kristy R Stengel, et al.
Molecular and Cellular Biology|March 17, 2004
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cellsCarsten Müller-Tidow, Björn Steffen, Thomas Cauvet, et al.
Plos One|July 30, 2013
Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphomaChristina E Wells, Srividya Bhaskara, Kristy R Stengel, et al.
Nature Medicine|July 2, 2002
The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemiaBryan Linggi, Carsten Müller-Tidow, Louis van de Locht, et al.
The Biochemical Journal|August 3, 2016
GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1Matthew Velinder, Jason Singer, Diana Bareyan, et al.
Nucleic Acids Research|October 23, 2012
The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κBElisabeth Ziesché, Daniela Kettner-Buhrow, Axel Weber, et al.
Cell Reports|August 9, 2016
High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AMLYue Zhao, Qi Liu, Pankaj Acharya, et al.
Oncogene|March 13, 2019
Kaiso is required for MTG16-dependent effects on colitis-associated carcinomaSarah P Short, Caitlyn W Barrett, Kristy R Stengel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid LeukemiaHaley E Ramsey, Dalton Greenwood, Susu Zhang, et al.
Pageof 10